首页> 外文期刊>Endocrine journal >Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy
【24h】

Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy

机译:甲状腺全切除术后甲状腺球蛋白抗体阳性的乳头状甲状腺癌早期复发的动态预后因素为血清甲状腺球蛋白抗体水平的变化

获取原文
获取原文并翻译 | 示例
       

摘要

We demonstrated previously that dynamic prognostic markers such as the thyroglobulin (Tg)-doubling time in thyroglobulin antibody (TgAb)-negative papillary thyroid carcinoma (PTC) and changes in pre- and postoperative TgAb levels in TgAb-positive PTC patients more keenly reflect patients' prognosis than conventional static prognostic factors. Here we investigated periodic changes in TgAb levels in 513 TgAb-positive PTC patients who underwent total thyroidectomy. The TgAb levels at 1 year after surgery decreased to <50% of the preoperative values in 407 (79%) patients, and the remaining 106 (21%) patients showed no decrease in TgAb. In 426 patients, TgAb was also measured more than 1 year after surgery. Compared with their TgAb levels 1 year after surgery, 59 patients (14%) showed an increase in TgAb levels of > 20% during the follow-up. The postoperative Tg levels at 1 year after surgery remained positive in 44 (9%) patients despite their TgAb positivity. To date (median follow-up period 35 months), 12 of the 426 patients (3%) showed PTC recurrence, and 11 of these patients showed either or both a TgAb elevation later than 1 year after surgery and postoperative Tg positivity. Although further studies with longer follow-ups are necessary, we can conclude that changes in postoperative TgAb levels may be usable as a surrogate tumor marker for TgAb-positive PTC patients after total thyroidectomy.
机译:我们先前证明了动态预后指标,例如甲状腺球蛋白抗体(TgAb)阴性乳头状甲状腺癌(PTC)中的甲状腺球蛋白(Tg)加倍时间以及TgAb阳性PTC患者术前和术后TgAb水平的变化更能敏锐地反映患者预后比常规的静态预后因素高。在这里,我们调查了接受全甲状腺切除术的513名TgAb阳性PTC患者的TgAb水平的周期性变化。术后1年的TgAb水平降至407例患者的术前值的<50%(79%),其余106例(21%)患者的TgAb没有降低。在426例患者中,手术后1年以上还测量了TgAb。与术后1年的TgAb水平相比,有59位患者(14%)随访期间TgAb水平增加了> 20%。尽管TgAb阳性,但术后1年的术后Tg水平仍在44例(9%)患者中保持阳性。迄今为止(中位随访期为35个月),在426例患者中有12例(3%)显示PTC复发,并且其中11例患者在手术后1年及术后Tg阳性均显示TgAb升高或升高。尽管有必要进行更长时间的随访研究,但我们可以得出结论,在甲状腺全切术后,TgAb水平的变化可能可以作为TgAb阳性PTC患者的替代肿瘤标志物。

著录项

  • 来源
    《Endocrine journal》 |2014年第10期|961-965|共5页
  • 作者单位

    Department of Head and Neck Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan, Clinical Trial Management Center, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Head and Neck Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    TgAb; Papillary thyroid carcinoma; Prognosis;

    机译:TgAb;甲状腺乳头状癌预后;
  • 入库时间 2022-08-18 01:32:30

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号